TLR2 and inflammatory bowel disease: The peptidoglycan of L. casei YIT 9029, L. johnsonii JCM 2012, and L. plantarum ATCC 14,917 has been reported to suppress IL-12 production via Toll-like receptor 2 (TLR2), which is associated with autoimmune and inflammatory bowel diseases [34].